Abiopharma

🔍 LORANGER STEVEN R (Director)

Company: Edwards Lifesciences Corp (EW)

Report Date: 2025-05-09

Detailed Transactions and Holdings:

• Acquired 3,528 shares of Common Stock (Direct)
  Date: 2025-05-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 63,900.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,154 shares of Common Stock (Direct)
  Date: 2025-05-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 65,054.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-05-09 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 15,000.00

Footnotes:

• F1: These restricted stock units were granted on May 9, 2025 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
• F2: This restricted stock award was granted on May 9, 2025 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
• REMARKS: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.